摘要
人ether-a-go-go-related gene(hERG)钾通道表达了延迟整流钾电流的快激活成分,对动作电位的复极至关重要。hERG钾电流不仅是抗心律失常作用的主要靶点,也是诸多药物增加尖端扭转型室速和心源性猝死风险的关键位点,而该电流的降低和(或)升高与基因突变或药物阻滞作用密切相关。随着对药物与hERG钾通道相互作用机制研究的深入,药物与通道孔道区蛋白结合位点的作用及其对通道转运的影响逐步被揭示,但这些药物对hERG作用的临床应用仍有待评价。
Human ether-a-go-go-related gene (hERG) potassium channels conduct the rapid component of the delayed rectifier potassium current (IKr). The reduction ( or increase) of IKr current due to either gene mutations or adverse drug effects would increase the risk of torsades de pointes and sudden cardiac death. This paper reviews various mechanisms of drug reactions of hERG potassium channels and the properties of major drug-protein reaction sites in the pore region and trafficking of hERG potassium channels under the influence of drugs. However, the effect of clinical administration of drugs on bERG remains unclear.
出处
《中国药理学与毒理学杂志》
CAS
CSCD
北大核心
2012年第4期581-584,共4页
Chinese Journal of Pharmacology and Toxicology
基金
国家自然科学基金资助项目(81170177)~~
关键词
HERG
药物反应
通道转运
钾通道
hERG
adverse drug reaction
channels trafficking
potassium channels